How should a patient with severe multiple sclerosis and moderate mitral regurgitation be managed perioperatively for laparoscopic cholecystectomy?

Management of Severe MS with Moderate MR for Laparoscopic Cholecystectomy

In a patient with severe multiple sclerosis (MS) and moderate mitral regurgitation (MR) undergoing laparoscopic cholecystectomy, proceed with surgery using careful hemodynamic monitoring, avoid hyperthermia and excessive stress, and maintain afterload reduction favorable to MR while preventing tachycardia. 1

Cardiac Management: Moderate Mitral Regurgitation

Preoperative Assessment

• It is reasonable to proceed with elective laparoscopic cholecystectomy in patients with moderate MR if they are asymptomatic, have normal LV systolic function, and estimated PA systolic pressure <50 mm Hg 1
• Confirm MR severity and LV function with preoperative echocardiography if not recently performed 1
• Assess for symptoms, pulmonary hypertension, and ventricular dysfunction that might warrant delaying surgery for cardiac intervention

Intraoperative Hemodynamic Goals for MR

The physiologic principles for moderate MR during laparoscopy include:

• Maintain low-normal afterload (avoid excessive hypertension that increases regurgitant fraction)
• Avoid significant bradycardia (maintain adequate forward cardiac output)
• Maintain adequate preload (but avoid volume overload)
• Monitor for hemodynamic changes from pneumoperitoneum, which increases SVR and can worsen MR 2

Monitoring Considerations

• Standard ASA monitoring is typically sufficient for moderate MR
• Consider arterial line for beat-to-beat BP monitoring given the dual challenges of MS and cardiac disease
• Advanced hemodynamic monitoring (FloTrac/arterial pressure-based cardiac output) may be beneficial given the combination of severe neurologic disease and cardiac pathology 3
• Invasive monitoring becomes more important if the patient develops hemodynamic instability

Common pitfall: Laparoscopic cholecystectomy causes significant hemodynamic changes even in cardiac patients—CO2 insufflation increases MAP, SVR, and PA pressures while decreasing cardiac index 2. In moderate MR, the increased afterload from pneumoperitoneum can acutely worsen regurgitant fraction.

Neurologic Management: Severe Multiple Sclerosis

Key Principles to Prevent MS Exacerbation

The primary perioperative risks for MS patients are:

• Hyperthermia (major trigger for exacerbation)
• Surgical stress response
• Infection/fever
• Physical trauma

Anesthetic Technique Recommendations

Preferred approach: Balanced general anesthesia with temperature control 4, 5

• Propofol and remifentanil/fentanyl infusions provide excellent stress response control 4, 5
• Volatile anesthetics (sevoflurane) are safe and commonly used 5, 6
• Avoid or minimize neuromuscular blockers due to unpredictable sensitivity in MS patients 5, 7
  • If intubation needed, consider propofol alone or minimal rocuronium with careful train-of-four monitoring
  • MS patients may have exaggerated responses to both depolarizing and non-depolarizing agents 7

Critical Perioperative Interventions

1. Aggressive temperature management:

   • Maintain normothermia intraoperatively (forced air warming, warmed fluids)
   • Monitor core temperature continuously
   • Treat any postoperative fever immediately with NSAIDs (e.g., flurbiprofen) 4

2. Stress response control:

   • Consider epidural anesthesia if not contraindicated by MS-related issues 4
   • Adequate depth of anesthesia throughout
   • Multimodal analgesia to minimize postoperative stress

3. Minimize infection risk:

   • Prophylactic antibiotics per surgical guidelines
   • Sterile technique
   • Early mobilization when possible

Common pitfall: Regional anesthesia (spinal/epidural) is controversial in MS. While some case reports show success with epidural 4, there is theoretical concern about exacerbating demyelination. The decision should weigh the benefits of stress reduction against potential neurologic risks.

Integrated Perioperative Algorithm

Preoperative

1. Confirm recent echocardiogram showing moderate MR with normal LV function and PA pressure <50 mmHg
2. Document baseline MS neurologic status carefully
3. Ensure patient is afebrile and without active MS exacerbation
4. Optimize cardiac medications (continue beta-blockers if on them)

Intraoperative

1. Anesthetic induction: Propofol + fentanyl, consider avoiding muscle relaxants or use minimal dose with monitoring 5
2. Maintenance: Propofol/remifentanil infusion + sevoflurane, or volatile-based technique 4, 5, 6
3. Hemodynamic management during pneumoperitoneum:
   • Expect increased SVR and decreased cardiac index 2
   • Use vasodilators (nitroglycerin) if MAP >100 mmHg or SVR >2000 dynes·sec/cm⁻⁵ to reduce MR afterload 2
   • Maintain adequate preload with judicious fluid administration
4. Temperature: Maintain normothermia aggressively
5. Positioning: Reverse Trendelenburg for laparoscopy may improve venous return but monitor BP closely 3

Postoperative

1. Extended monitoring in PACU or step-down unit given dual pathology
2. Immediate fever treatment if temperature >38°C 4
3. Early neurologic assessment to detect MS exacerbation
4. Multimodal analgesia to minimize stress response
5. Early mobilization when safe to prevent complications

Evidence Quality Note

The cardiac recommendations are based on high-quality 2024 ACC/AHA guidelines 1. However, MS anesthetic management relies on case reports and small case series 4, 5, 6, as randomized trials are lacking. The principles of avoiding hyperthermia, minimizing stress, and careful neuromuscular blocker use are consistently emphasized across all available literature 4, 5, 7, 6.